{"nct_id":"NCT05032157","title":"A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2021-12-01","start_date_type":"ACTUAL","primary_completion_date":"2023-12-18","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}